Email Us
View Reports

Global Neuroendocrine Tumor Drug Market Research Report 2018

  • ID : 26954315  |  
  • Published : May-2018  |  
  • Region : Global  |  
  • Pages : 114   |  
  • Publisher : QY Research

This report studies the global Neuroendocrine Tumor Drug market status and forecast, categorizes the global Neuroendocrine Tumor Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

In 2017, the global Neuroendocrine Tumor Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report

Eisai

Exelixis, Inc.

Foresee Pharmaceuticals, LLC

Hutchison MediPharma Limited

Intezyne, Inc

INVENT Pharmaceuticals, Inc.

Ipsen S.A.

Jiangsu Hengrui Medicine Co., Ltd.

Karyopharm Therapeutics, Inc.

Lexicon Pharmaceuticals, Inc.

Midatech Pharma Plc .

Millennium Pharmaceuticals, Inc.

MolMed S.p.A.

Northwest Biotherapeutics, Inc.

Novartis AG

OctreoPharm Sciences GmbH

OXiGENE, Inc.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

North America

Europe

Asia-Pacific

South America

Middle East & Africa

The regional scope of the study is as follows:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Saudi Arabia

Turkey

Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

mTOR protein inhibitors

Tyrosine kinase 3 inhibitors

Somatostatin receptor antagonists

Growth hormone releasing factor antagonists

Somatostatin receptor agonists

Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Hospital

Clinic

Others

The study objectives of this report are:

To analyze and study the global Neuroendocrine Tumor Drug sales, value, status (2013-2017) and forecast (2018-2025).

Focuses on the key Neuroendocrine Tumor Drug manufacturers, to study the sales, value, market share and development plans in future.

Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Neuroendocrine Tumor Drug are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Neuroendocrine Tumor Drug Manufacturers

Neuroendocrine Tumor Drug Distributors/Traders/Wholesalers

Neuroendocrine Tumor Drug Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Neuroendocrine Tumor Drug market, by end-use.

Detailed analysis and profiles of additional market players.

Table of Contents

Global Neuroendocrine Tumor Drug Market Research Report 2018

1 Neuroendocrine Tumor Drug Market Overview

1.1 Product Overview and Scope of Neuroendocrine Tumor Drug

1.2 Neuroendocrine Tumor Drug Segment by Type (Product Category)

1.2.1 Global Neuroendocrine Tumor Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)

1.2.2 Global Neuroendocrine Tumor Drug Production Market Share by Type (Product Category) in 2017

1.2.3 mTOR protein inhibitors

1.2.4 Tyrosine kinase 3 inhibitors

1.2.5 Somatostatin receptor antagonists

1.2.6 Growth hormone releasing factor antagonists

1.2.7 Somatostatin receptor agonists

1.2.8 Others

1.3 Global Neuroendocrine Tumor Drug Segment by Application

1.3.1 Neuroendocrine Tumor Drug Consumption (Sales) Comparison by Application (2013-2025)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Neuroendocrine Tumor Drug Market by Region (2013-2025)

1.4.1 Global Neuroendocrine Tumor Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)

1.4.2 North America Status and Prospect (2013-2025)

1.4.3 Europe Status and Prospect (2013-2025)

1.4.4 Asia-Pacific Status and Prospect (2013-2025)

1.4.5 South America Status and Prospect (2013-2025)

1.4.6 Middle East & Africa Status and Prospect (2013-2025)

1.5 Global Market Size (Value) of Neuroendocrine Tumor Drug (2013-2025)

1.5.1 Global Neuroendocrine Tumor Drug Revenue Status and Outlook (2013-2025)

1.5.2 Global Neuroendocrine Tumor Drug Capacity, Production Status and Outlook (2013-2025)

2 Global Neuroendocrine Tumor Drug Market Competition by Manufacturers

2.1 Global Neuroendocrine Tumor Drug Capacity, Production and Share by Manufacturers (2013-2018)

2.1.1 Global Neuroendocrine Tumor Drug Capacity and Share by Manufacturers (2013-2018)

2.1.2 Global Neuroendocrine Tumor Drug Production and Share by Manufacturers (2013-2018)

2.2 Global Neuroendocrine Tumor Drug Revenue and Share by Manufacturers (2013-2018)

2.3 Global Neuroendocrine Tumor Drug Average Price by Manufacturers (2013-2018)

2.4 Manufacturers Neuroendocrine Tumor Drug Manufacturing Base Distribution, Sales Area and Product Type

2.5 Neuroendocrine Tumor Drug Market Competitive Situation and Trends

2.5.1 Neuroendocrine Tumor Drug Market Concentration Rate

2.5.2 Neuroendocrine Tumor Drug Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Neuroendocrine Tumor Drug Capacity, Production, Revenue (Value) by Region (2013-2018)

3.1 Global Neuroendocrine Tumor Drug Capacity and Market Share by Region (2013-2018)

3.2 Global Neuroendocrine Tumor Drug Production and Market Share by Region (2013-2018)

3.3 Global Neuroendocrine Tumor Drug Revenue (Value) and Market Share by Region (2013-2018)

3.4 Global Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.5 North America Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.6 Europe Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.7 Asia-Pacific Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.8 South America Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.9 Middle East & Africa Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Neuroendocrine Tumor Drug Supply (Production), Consumption, Export, Import by Region (2013-2018)

4.1 Global Neuroendocrine Tumor Drug Consumption by Region (2013-2018)

4.2 North America Neuroendocrine Tumor Drug Production, Consumption, Export, Import (2013-2018)

4.3 Europe Neuroendocrine Tumor Drug Production, Consumption, Export, Import (2013-2018)

4.4 Asia-Pacific Neuroendocrine Tumor Drug Production, Consumption, Export, Import (2013-2018)

4.5 South America Neuroendocrine Tumor Drug Production, Consumption, Export, Import (2013-2018)

4.6 Middle East & Africa Neuroendocrine Tumor Drug Production, Consumption, Export, Import (2013-2018)

5 Global Neuroendocrine Tumor Drug Production, Revenue (Value), Price Trend by Type

5.1 Global Neuroendocrine Tumor Drug Production and Market Share by Type (2013-2018)

5.2 Global Neuroendocrine Tumor Drug Revenue and Market Share by Type (2013-2018)

5.3 Global Neuroendocrine Tumor Drug Price by Type (2013-2018)

5.4 Global Neuroendocrine Tumor Drug Production Growth by Type (2013-2018)

6 Global Neuroendocrine Tumor Drug Market Analysis by Application

6.1 Global Neuroendocrine Tumor Drug Consumption and Market Share by Application (2013-2018)

6.2 Global Neuroendocrine Tumor Drug Consumption Growth Rate by Application (2013-2018)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Neuroendocrine Tumor Drug Manufacturers Profiles/Analysis

7.1 Eisai

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Neuroendocrine Tumor Drug Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 Eisai Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.1.4 Main Business/Business Overview

7.2 Exelixis, Inc.

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Neuroendocrine Tumor Drug Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Exelixis, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.2.4 Main Business/Business Overview

7.3 Foresee Pharmaceuticals, LLC

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Neuroendocrine Tumor Drug Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.3.4 Main Business/Business Overview

7.4 Hutchison MediPharma Limited

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Neuroendocrine Tumor Drug Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.4.4 Main Business/Business Overview

7.5 Intezyne, Inc

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Neuroendocrine Tumor Drug Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Intezyne, Inc Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.5.4 Main Business/Business Overview

7.6 INVENT Pharmaceuticals, Inc.

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Neuroendocrine Tumor Drug Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.6.4 Main Business/Business Overview

7.7 Ipsen S.A.

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Neuroendocrine Tumor Drug Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Ipsen S.A. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.7.4 Main Business/Business Overview

7.8 Jiangsu Hengrui Medicine Co., Ltd.

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Neuroendocrine Tumor Drug Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.8.4 Main Business/Business Overview

7.9 Karyopharm Therapeutics, Inc.

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Neuroendocrine Tumor Drug Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.9.4 Main Business/Business Overview

7.10 Lexicon Pharmaceuticals, Inc.

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 Neuroendocrine Tumor Drug Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.10.4 Main Business/Business Overview

7.11 Midatech Pharma Plc .

7.12 Millennium Pharmaceuticals, Inc.

7.13 MolMed S.p.A.

7.14 Northwest Biotherapeutics, Inc.

7.15 Novartis AG

7.16 OctreoPharm Sciences GmbH

7.17 OXiGENE, Inc.

8 Neuroendocrine Tumor Drug Manufacturing Cost Analysis

8.1 Neuroendocrine Tumor Drug Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Neuroendocrine Tumor Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Neuroendocrine Tumor Drug Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Neuroendocrine Tumor Drug Major Manufacturers in 2017

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Neuroendocrine Tumor Drug Market Forecast (2018-2025)

12.1 Global Neuroendocrine Tumor Drug Capacity, Production, Revenue Forecast (2018-2025)

12.1.1 Global Neuroendocrine Tumor Drug Capacity, Production and Growth Rate Forecast (2018-2025)

12.1.2 Global Neuroendocrine Tumor Drug Revenue and Growth Rate Forecast (2018-2025)

12.1.3 Global Neuroendocrine Tumor Drug Price and Trend Forecast (2018-2025)

12.2 Global Neuroendocrine Tumor Drug Production, Consumption , Import and Export Forecast by Region (2018-2025)

12.2.1 North America Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.2 Europe Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.3 Asia-Pacific Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.4 South America Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.5 Middle East & Africa Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.3 Global Neuroendocrine Tumor Drug Production, Revenue and Price Forecast by Type (2018-2025)

12.4 Global Neuroendocrine Tumor Drug Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

List of Tables and Figures

Figure Picture of Neuroendocrine Tumor Drug

Figure Global Neuroendocrine Tumor Drug Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)

Figure Global Neuroendocrine Tumor Drug Production Market Share by Types (Product Category) in 2017

Figure Product Picture of mTOR protein inhibitors

Table Major Manufacturers of mTOR protein inhibitors

Figure Product Picture of Tyrosine kinase 3 inhibitors

Table Major Manufacturers of Tyrosine kinase 3 inhibitors

Figure Product Picture of Somatostatin receptor antagonists

Table Major Manufacturers of Somatostatin receptor antagonists

Figure Product Picture of Growth hormone releasing factor antagonists

Table Major Manufacturers of Growth hormone releasing factor antagonists

Figure Product Picture of Somatostatin receptor agonists

Table Major Manufacturers of Somatostatin receptor agonists

Figure Product Picture of Others

Table Major Manufacturers of Others

Figure Global Neuroendocrine Tumor Drug Consumption (K Pcs) by Applications (2013-2025)

Figure Global Neuroendocrine Tumor Drug Consumption Market Share by Applications in 2017

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Others Examples

Table Key Downstream Customer in Others

Figure Global Neuroendocrine Tumor Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2013-2025)

Figure North America Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure Europe Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure Asia-Pacific Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure South America Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure Middle East & Africa Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure Global Neuroendocrine Tumor Drug Revenue (Million USD) Status and Outlook (2013-2025)

Figure Global Neuroendocrine Tumor Drug Capacity, Production (K Pcs) Status and Outlook (2013-2025)

Figure Global Neuroendocrine Tumor Drug Major Players Product Capacity (K Pcs) (2013-2018)

Table Global Neuroendocrine Tumor Drug Capacity (K Pcs) of Key Manufacturers (2013-2018)

Table Global Neuroendocrine Tumor Drug Capacity Market Share of Key Manufacturers (2013-2018)

Figure Global Neuroendocrine Tumor Drug Capacity (K Pcs) of Key Manufacturers in 2017

Figure Global Neuroendocrine Tumor Drug Capacity (K Pcs) of Key Manufacturers in 2018

Figure Global Neuroendocrine Tumor Drug Major Players Product Production (K Pcs) (2013-2018)

Table Global Neuroendocrine Tumor Drug Production (K Pcs) of Key Manufacturers (2013-2018)

Table Global Neuroendocrine Tumor Drug Production Share by Manufacturers (2013-2018)

Figure 2017 Neuroendocrine Tumor Drug Production Share by Manufacturers

Figure 2017 Neuroendocrine Tumor Drug Production Share by Manufacturers

Figure Global Neuroendocrine Tumor Drug Major Players Product Revenue (Million USD) (2013-2018)

Table Global Neuroendocrine Tumor Drug Revenue (Million USD) by Manufacturers (2013-2018)

Table Global Neuroendocrine Tumor Drug Revenue Share by Manufacturers (2013-2018)

Table 2017 Global Neuroendocrine Tumor Drug Revenue Share by Manufacturers

Table 2018 Global Neuroendocrine Tumor Drug Revenue Share by Manufacturers

Table Global Market Neuroendocrine Tumor Drug Average Price (USD/Pcs) of Key Manufacturers (2013-2018)

Figure Global Market Neuroendocrine Tumor Drug Average Price (USD/Pcs) of Key Manufacturers in 2017

Table Manufacturers Neuroendocrine Tumor Drug Manufacturing Base Distribution and Sales Area

Table Manufacturers Neuroendocrine Tumor Drug Product Category

Figure Neuroendocrine Tumor Drug Market Share of Top 3 Manufacturers

Figure Neuroendocrine Tumor Drug Market Share of Top 5 Manufacturers

Table Global Neuroendocrine Tumor Drug Capacity (K Pcs) by Region (2013-2018)

Figure Global Neuroendocrine Tumor Drug Capacity Market Share by Region (2013-2018)

Figure Global Neuroendocrine Tumor Drug Capacity Market Share by Region (2013-2018)

Figure 2017 Global Neuroendocrine Tumor Drug Capacity Market Share by Region

Table Global Neuroendocrine Tumor Drug Production by Region (2013-2018)

Figure Global Neuroendocrine Tumor Drug Production (K Pcs) by Region (2013-2018)

Figure Global Neuroendocrine Tumor Drug Production Market Share by Region (2013-2018)

Figure 2017 Global Neuroendocrine Tumor Drug Production Market Share by Region

Table Global Neuroendocrine Tumor Drug Revenue (Million USD) by Region (2013-2018)

Table Global Neuroendocrine Tumor Drug Revenue Market Share by Region (2013-2018)

Figure Global Neuroendocrine Tumor Drug Revenue Market Share by Region (2013-2018)

Table 2017 Global Neuroendocrine Tumor Drug Revenue Market Share by Region

Figure Global Neuroendocrine Tumor Drug Capacity, Production (K Pcs) and Growth Rate (2013-2018)

Table Global Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Table North America Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Table Europe Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Table Asia-Pacific Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Table South America Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Table Middle East & Africa Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Table Global Neuroendocrine Tumor Drug Consumption (K Pcs) Market by Region (2013-2018)

Table Global Neuroendocrine Tumor Drug Consumption Market Share by Region (2013-2018)

Figure Global Neuroendocrine Tumor Drug Consumption Market Share by Region (2013-2018)

Figure 2017 Global Neuroendocrine Tumor Drug Consumption (K Pcs) Market Share by Region

Table North America Neuroendocrine Tumor Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)

Table Europe Neuroendocrine Tumor Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)

Table Asia-Pacific Neuroendocrine Tumor Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)

Table South America Neuroendocrine Tumor Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)

Table Middle East & Africa Neuroendocrine Tumor Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)

Table Global Neuroendocrine Tumor Drug Production (K Pcs) by Type (2013-2018)

Table Global Neuroendocrine Tumor Drug Production Share by Type (2013-2018)

Figure Production Market Share of Neuroendocrine Tumor Drug by Type (2013-2018)

Figure 2017 Production Market Share of Neuroendocrine Tumor Drug by Type

Table Global Neuroendocrine Tumor Drug Revenue (Million USD) by Type (2013-2018)

Table Global Neuroendocrine Tumor Drug Revenue Share by Type (2013-2018)

Figure Production Revenue Share of Neuroendocrine Tumor Drug by Type (2013-2018)

Figure 2017 Revenue Market Share of Neuroendocrine Tumor Drug by Type

Table Global Neuroendocrine Tumor Drug Price (USD/Pcs) by Type (2013-2018)

Figure Global Neuroendocrine Tumor Drug Production Growth by Type (2013-2018)

Table Global Neuroendocrine Tumor Drug Consumption (K Pcs) by Application (2013-2018)

Table Global Neuroendocrine Tumor Drug Consumption Market Share by Application (2013-2018)

Figure Global Neuroendocrine Tumor Drug Consumption Market Share by Applications (2013-2018)

Figure Global Neuroendocrine Tumor Drug Consumption Market Share by Application in 2017

Table Global Neuroendocrine Tumor Drug Consumption Growth Rate by Application (2013-2018)

Figure Global Neuroendocrine Tumor Drug Consumption Growth Rate by Application (2013-2018)

Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eisai Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Eisai Neuroendocrine Tumor Drug Production Growth Rate (2013-2018)

Figure Eisai Neuroendocrine Tumor Drug Production Market Share (2013-2018)

Figure Eisai Neuroendocrine Tumor Drug Revenue Market Share (2013-2018)

Table Exelixis, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Exelixis, Inc. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Exelixis, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2013-2018)

Figure Exelixis, Inc. Neuroendocrine Tumor Drug Production Market Share (2013-2018)

Figure Exelixis, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2013-2018)

Table Foresee Pharmaceuticals, LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production Growth Rate (2013-2018)

Figure Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production Market Share (2013-2018)

Figure Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Revenue Market Share (2013-2018)

Table Hutchison MediPharma Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Hutchison MediPharma Limited Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production Growth Rate (2013-2018)

Figure Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production Market Share (2013-2018)

Figure Hutchison MediPharma Limited Neuroendocrine Tumor Drug Revenue Market Share (2013-2018)

Table Intezyne, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Intezyne, Inc Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Intezyne, Inc Neuroendocrine Tumor Drug Production Growth Rate (2013-2018)

Figure Intezyne, Inc Neuroendocrine Tumor Drug Production Market Share (2013-2018)

Figure Intezyne, Inc Neuroendocrine Tumor Drug Revenue Market Share (2013-2018)

Table INVENT Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2013-2018)

Figure INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Market Share (2013-2018)

Figure INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2013-2018)

Table Ipsen S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Ipsen S.A. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Ipsen S.A. Neuroendocrine Tumor Drug Production Growth Rate (2013-2018)

Figure Ipsen S.A. Neuroendocrine Tumor Drug Production Market Share (2013-2018)

Figure Ipsen S.A. Neuroendocrine Tumor Drug Revenue Market Share (2013-2018)

Table Jiangsu Hengrui Medicine Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production Growth Rate (2013-2018)

Figure Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production Market Share (2013-2018)

Figure Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Revenue Market Share (2013-2018)

Table Karyopharm Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2013-2018)

Figure Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production Market Share (2013-2018)

Figure Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2013-2018)

Table Lexicon Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2013-2018)

Figure Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Market Share (2013-2018)

Figure Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2013-2018)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Neuroendocrine Tumor Drug

Figure Manufacturing Process Analysis of Neuroendocrine Tumor Drug

Figure Neuroendocrine Tumor Drug Industrial Chain Analysis

Table Raw Materials Sources of Neuroendocrine Tumor Drug Major Manufacturers in 2017

Table Major Buyers of Neuroendocrine Tumor Drug

Table Distributors/Traders List

Figure Global Neuroendocrine Tumor Drug Capacity, Production (K Pcs) and Growth Rate Forecast (2018-2025)

Figure Global Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Global Neuroendocrine Tumor Drug Price (Million USD) and Trend Forecast (2018-2025)

Table Global Neuroendocrine Tumor Drug Production (K Pcs) Forecast by Region (2018-2025)

Figure Global Neuroendocrine Tumor Drug Production Market Share Forecast by Region (2018-2025)

Table Global Neuroendocrine Tumor Drug Consumption (K Pcs) Forecast by Region (2018-2025)

Figure Global Neuroendocrine Tumor Drug Consumption Market Share Forecast by Region (2018-2025)

Figure North America Neuroendocrine Tumor Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)

Figure North America Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table North America Neuroendocrine Tumor Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)

Figure Europe Neuroendocrine Tumor Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)

Figure Europe Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Europe Neuroendocrine Tumor Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)

Figure Asia-Pacific Neuroendocrine Tumor Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)

Figure Asia-Pacific Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Asia-Pacific Neuroendocrine Tumor Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)

Figure South America Neuroendocrine Tumor Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)

Figure South America Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table South America Neuroendocrine Tumor Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)

Figure Middle East & Africa Neuroendocrine Tumor Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)

Figure Middle East & Africa Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Middle East & Africa Neuroendocrine Tumor Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)

Table Global Neuroendocrine Tumor Drug Production (K Pcs) Forecast by Type (2018-2025)

Figure Global Neuroendocrine Tumor Drug Production (K Pcs) Forecast by Type (2018-2025)

Table Global Neuroendocrine Tumor Drug Revenue (Million USD) Forecast by Type (2018-2025)

Figure Global Neuroendocrine Tumor Drug Revenue Market Share Forecast by Type (2018-2025)

Table Global Neuroendocrine Tumor Drug Price Forecast by Type (2018-2025)

Table Global Neuroendocrine Tumor Drug Consumption (K Pcs) Forecast by Application (2018-2025)

Figure Global Neuroendocrine Tumor Drug Consumption (K Pcs) Forecast by Application (2018-2025)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Source

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?